quantitative
Analysis v1
Strong Support

People without diabetes who are overweight or obese and take a weekly 2.4 mg dose of semaglutide often get mild stomach issues like nausea, diarrhea, or vomiting, but most keep taking it — only a small number stop because of these side effects.

82
Pro
0
Against

Evidence from Studies

Supporting (1)

82

Community contributions welcome

82

Once-Weekly Semaglutide in Adults with Overweight or Obesity.

Randomized Controlled Trial
Human
2021 Mar 18

The study looked at the same medicine and dose as the claim and found similar stomach-related side effects that were usually mild and went away over time, with slightly more people stopping the drug because of these issues compared to placebo.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.